Jeffrey S. Hatfield Insider Trading $LIFE aTYR PHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey S. Hatfield.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey S. Hatfield. Jeffrey S. Hatfield is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Chief Executive Officer in Vitae Pharmaceuticals, Inc ($VTAE) and Director in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV) and Director in aTYR PHARMA INC ($LIFE) and Chief Executive Officer in ZAFGEN, INC. ($ZFGN) and Director in MIRAGEN THERAPEUTICS, INC. ($MGEN) and Director in Vir Biotechnology, Inc. ($VIR).

Jeffrey S. Hatfield in aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jeffrey S. Hatfield: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2020
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeffrey S. Hatfield in aTYR PHARMA INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AMBI, LIFE, NVIV, LRMR, VIR, MGEN, VTAE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
May 08 2020	LIFE	aTYR PHARMA INC	Hatfield Jeffrey S.	Director	Option Exercise	A	3.65	1,428	5,212	1,428
May 10 2019	LIFE	aTYR PHARMA INC	Hatfield Jeffrey S.	Director	Option Exercise	A	0.58	20,000	11,668	20,000
May 17 2018	LIFE	aTYR PHARMA INC	Hatfield Jeffrey S.	Director	Option Exercise	A	1.35	20,000	27,000	20,000
May 11 2017	LIFE	aTYR PHARMA INC	Hatfield Jeffrey S.	Director	Option Exercise	A	3.15	20,000	63,000	20,000

Page: 1